Letter to the editor

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 18, Issue 2, 2001, Pages 201-

  Bouros, D ^a   Antoniou, K M ^a   Siafakas, N M ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Adverse reaction; Deep venous thrombosis; Interferon

Indexed keywords

ANTITHROMBIN III; CARBON DIOXIDE; ESTROGEN; GAMMA INTERFERON; OXYGEN; PREDNISONE; PROTEIN C; PROTEIN S; ANTIVIRUS AGENT;

AGED; ARTERIAL PRESSURE; BONE PAIN; CASE REPORT; CHILL; DEEP VEIN THROMBOSIS; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; IMMUNOTHERAPY; LETTER; MYALGIA; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; TOTAL LUNG CAPACITY; CHEMICALLY INDUCED DISORDER; PNEUMONIA; VEIN THROMBOSIS;

AGED; ANTIVIRAL AGENTS; FEMALE; HUMANS; INTERFERON TYPE II; PNEUMONIA; VENOUS THROMBOSIS;

EID: 0034961642     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease
2. Enlargement of the thymus in a child with chronic granulomatous disease receiving interferon gamma therapy
3. Interferon-gamma induced exacerbation of systemic lupus erytbematosus
4. Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis
5. Sarcoidosis following beta-interferon therapy for multiple myeloma
6. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C